期刊
CLINICAL INFECTIOUS DISEASES
卷 75, 期 1, 页码 E350-E353出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciac032
关键词
genomic surveillance; multiplex PCR; Omicron; SARS-CoV-2; vaccine
资金
- Centers for Disease Control and Prevention (CDC) [75D30121C10084, BAA ERR 20-15-2997]
- National Institutes of Health (NIH) [U54 EB027690 02S1, U54 EB027690 03S1, U54EB027690 03S2, UL1TR002378]
- NIH [P51 OD011132, 3U19AI057266-17S1, 1U54CA260563]
- NIH/National Institute of Allergy and Infectious Diseases (NIAID) Centers of Excellence for Influenza Research and Response (CEIRR)\Center of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400004C]
- NIAID NIH [75N93021C00017]
- NIAID
- Emory Executive Vice President for Health Affairs Synergy Fund award
- Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children's Healthcare of Atlanta
- Emory-University of Georgia Center of Excellence for Influenza Research and Surveillance (Atlanta, Georgia)
- Woodruff Health Sciences Center
- Emory School of Medicine
- Emory Woodruff Health Sciences Center COVID-19 Urgent Research Engagement Center
- O. Wayne Rollins Foundation
- William Randolph Hearst Foundation
This article describes the rapid detection of the SARS-CoV-2 Omicron variant through targeted spike single-nucleotide polymorphism polymerase chain reaction and viral genome sequencing. The case occurred in a fully vaccinated and boosted traveler with mild symptoms, and was identified through community surveillance rather than clinical care.
We describe rapid detection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant using targeted spike single-nucleotide polymorphism polymerase chain reaction and viral genome sequencing. This case occurred in a fully vaccinated and boosted returning traveler with mild symptoms who was identified through community surveillance rather than clinical care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
